Somatostatin Acetate
Native somatostatin for hemostasis and pancreatic applications. Broad-spectrum inhibitor of growth hormone, insulin, and glucagon secretion for acute hormonal control.
Somatostatin is a naturally occurring tetradecapeptide (14 amino acids) cyclic hormone produced primarily in the hypothalamus and pancreatic D-cells. It acts as a potent inhibitor of multiple endocrine and exocrine secretions, including growth hormone, insulin, glucagon, and gastrin. It is widely used in the emergency treatment of acute upper gastrointestinal bleeding, particularly esophageal variceal hemorrhage, and in the perioperative management of gastrointestinal pancreatic endocrine tumors.
| Parameter | Specification |
| CAS | 38916-34-6 |
| Molecular Formula | C₇₆H₁₀₄N₁₈O₁₉S₂ |
| Molecular Weight | 1637.89 g/mol |
| Category | Oncology/Endocrine |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | GI bleeding, pancreatic surgery, hormone suppression, acute hyperglycemia |
| CAS | 38916-34-6 |
|---|---|
| Applications | GI Bleeding, Growth Hormone Release Inhibitor, Perioperative Management |
Related products
-
Setmelanotide
CAS: 920014-72-8Applications: Appetite Regulation, Genetic Obesity, MC4R Agonist, metabolic syndrome -
Alarelin
CAS: 79561-22-1Applications: Assisted Reproduction, Endometriosis, Hormone-dependent Tumors, Uterine Fibroids -
Teduglutide
CAS: 197922-42-2Applications: Crohn Disease, GLP-2, Intestinal Repair, Short Bowel Syndrome -
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management